Do not miss this multidisciplinary and exciting perspective session on clinical trials for #AtypicalAD on July 29!
@rikossenkoppele.bsky.social @neusfalgas.bsky.social @corriveaunick.bsky.social @neguine.bsky.social @istaart.bsky.social
Do not miss this multidisciplinary and exciting perspective session on clinical trials for #AtypicalAD on July 29!
@rikossenkoppele.bsky.social @neusfalgas.bsky.social @corriveaunick.bsky.social @neguine.bsky.social @istaart.bsky.social
🗓️ Mark your calendars & join @istaart.bsky.social lunchtime intermissions to network and discuss synergistic efforts with not one but two Atypical AD PIA workgroups!
🗓️ Mark your calendars & join @istaart.bsky.social lunchtime intermissions to network and discuss synergistic efforts with not one but two Atypical AD PIA workgroups!
Join the conversation with @rikossenkoppele.bsky.social, Dr. Keir Yong & myself to debate whether individuals with atypical Alzheimer's disease should be included in clinical trials.
Join the conversation with @rikossenkoppele.bsky.social, Dr. Keir Yong & myself to debate whether individuals with atypical Alzheimer's disease should be included in clinical trials.
🔗 Register here: alz-org.zoom.us/webinar/regi...
🔗 Register here: alz-org.zoom.us/webinar/regi...
Register here:
alz-org.zoom.us/webinar/regi...
Register here:
alz-org.zoom.us/webinar/regi...